🏢 官网IRTVTXCodex · 实盘不做把握 9/10
北京时间·🕒 发布 04:30:00(美东 08-05 16:30)·⟳ 抓取 04:32:25·⚡ 决策 08-06 04:35:47 +3m22s·82.7 天前
Travere Therapeutics 宣布管理层将参加多场投资者会议
这是公司例行投资者会议出席公告，只披露会议时间和 webcast 安排，没有药品进展、监管节点、订单、财务指引或商业化增量。
📄 原文TVTX↗ 原文
Travere Therapeutics to Participate at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)-- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will par…
不做 Travere Therapeutics（TVTX.US）
例行投资者会议出席公告，无明确方向、无可量化基本面增量，也没有可执行同向交易 edge，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-05 · 扩散 low · price-in 风险 low ↗
关键理由
- 这是公司例行投资者会议出席公告，只披露会议时间和 webcast 安排，没有药品进展、监管节点、订单、财务指引或商业化增量。
主要风险
- 若会议后另行披露实质性临床、商业化或财务信息，应由新信号重新研判。
原文全文
展开原文 · 1,553 字
SAN DIEGO--(BUSINESS WIRE)--
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences:
Canaccord Genuity's 46th Annual Growth Conference
Presenting on Tuesday, August 11, 2026, at 3:00 p.m. ET
Wells Fargo 21st Annual Healthcare Conference
Tuesday, September 8, 2026
Citi 2026 Biopharma Back to School Conference
Wednesday, September 9, 2026
2026 Cantor Global Healthcare Conference
Presenting on Thursday, September 10, 2026, at 9:10 a.m. ET
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at
ir.travere.com/events-and-presentations
. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit
travere.com
.
Investors:
888-969-7879
ir@travere.com
Media:
888-969-7879
mediarelations@travere.com
Source: Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences:
Canaccord Genuity's 46th Annual Growth Conference
Presenting on Tuesday, August 11, 2026, at 3:00 p.m. ET
Wells Fargo 21st Annual Healthcare Conference
Tuesday, September 8, 2026
Citi 2026 Biopharma Back to School Conference
Wednesday, September 9, 2026
2026 Cantor Global Healthcare Conference
Presenting on Thursday, September 10, 2026, at 9:10 a.m. ET
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at
ir.travere.com/events-and-presentations
. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit
travere.com
.
Investors:
888-969-7879
ir@travere.com
Media:
888-969-7879
mediarelations@travere.com
Source: Travere Therapeutics, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。